Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$70.92 USD
-0.57 (-0.80%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $70.79 -0.13 (-0.18%) 6:16 PM ET
4-Sell of 5 4
C Value C Growth C Momentum B VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Bottom 36% (162 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.80 | 1.42 | 9.99 |
Current Quarter Estimate | 0.86 | 1.25 | 60.00 |
Year Ago Quarter Estimate | 0.70 | -4.28 | 52.54 |
Next Quarter Estimate | 1.10 | 1.37 | 61.00 |
Next Year Estimate | 4.12 | 7.08 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 20.00 | 21.80 | 5.37 |
Next Year | 4.04 | 11.20 | 11.11 |
Last 5 Years | 21.10 | 0.80 | 8.10 |
Next 5 Years | 9.70 | 8.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 18.86 | 1.64 |
Price/Book (MRQ) | 3.70 | 1.06 |
Price/Cash Flow (MRFY) | 16.97 | 10.01 |
Dividend Yield | 0.57% | 0.00% |
Net Profit Margin (TTM) | 19.26% | NA |
Return on Equity (TTM) | 20.97% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.